High Court Seeks U.S. Opinion On Tamoxifen Case
On Monday, the Supreme Court requested a brief from the U.S. Solicitor General's office, sparking speculation that the nation’s highest court may be leaning towards taking on the case.
Barr and AstraZeneca have been under legal fire since 2003, when consumers and others filed over 30 class action suits...
To view the full article, register now.